SNF Emerging Watchlist™ Research Report
An evidence-led review of 17 newly public companies positioned around the economic themes that may shape the next decade.
24 pages | Published September 18, 2026 | Free PDF
Four material thesis updates
ARR growth, SaaS adoption, RPO expansion, AI monetization and positive free cash flow supported promotion from Candidate.
AI infrastructure demand remains exceptional, while convertible debt and equity issuance capacity increased durability risk.
IPO funding and clinical execution strengthened, but larger Phase 2 and Phase 3 evidence remains the confirmation point.
Funded backlog, TRISO economics and customer validation strengthened while authorization and repeat production remain ahead.
Theme is the starting point. Evidence determines the classification.
Six evidence families
Structural theme, business quality, growth and traction, competitive position, financial durability and market confirmation.
Lifecycle, not ratings
Candidate and Watching describe the maturity of the evidence package. They are not buy, sell or hold recommendations.
Price moves score zero
Post-IPO performance can attract research attention, but it contributes zero points to the Emerging Score.
The September 18 Watchlist
Select a company for the complete thesis, SNF Lens, six-family scorecard, evidence ledger and review history.
Read the complete September research
Download the full report for the cohort dashboard, decision log, company scorecards, confirmation calendar, methodology and primary-source notes.
Download the 24-Page PDFResearch and monitoring context only. Not investment advice, a price target, forecast return, trade signal or recommendation to buy, sell or hold any security.